These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 20187858

  • 1. Almotriptan for the treatment of acute migraine: a review of early intervention trials.
    Antonaci F, De Cillis I, Cuzzoni MG, Allena M.
    Expert Rev Neurother; 2010 Mar; 10(3):351-64. PubMed ID: 20187858
    [Abstract] [Full Text] [Related]

  • 2. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
    Mathew NT, Finlayson G, Smith TR, Cady RK, Adelman J, Mao L, Wright P, Greenberg SJ, AEGIS Investigator Study Group.
    Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
    [Abstract] [Full Text] [Related]

  • 3. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG, Finlayson G, Rapoport AM, Elkind AH, Diamond ML, Unger JR, Fisher AC, Armstrong RB, Hulihan JF, Greenberg SJ, AIMS Investigators.
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [Abstract] [Full Text] [Related]

  • 4. The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.
    Goadsby PJ.
    Cephalalgia; 2008 Sep; 28 Suppl 2():36-41. PubMed ID: 18715331
    [Abstract] [Full Text] [Related]

  • 5. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
    Diamond ML, Cady RK, Mao L, Biondi DM, Finlayson G, Greenberg SJ, Wright P.
    Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
    [Abstract] [Full Text] [Related]

  • 6. Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention.
    Cady RK, Freitag FG, Mathew NT, Elkind AH, Mao L, Fisher AC, Biondi DM, Finlayson G, Greenberg SJ, Hulihan JF.
    Headache; 2009 Mar; 49(3):350-63. PubMed ID: 19220503
    [Abstract] [Full Text] [Related]

  • 7. Almotriptan: meeting today's needs in acute migraine treatment.
    Láinez MJ.
    Expert Rev Neurother; 2007 Dec; 7(12):1659-73. PubMed ID: 18052762
    [Abstract] [Full Text] [Related]

  • 8. Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine.
    Sandrini G, Dahlöf CG, Mathew N, Nappi G.
    Int J Clin Pract; 2005 Nov; 59(11):1356-65. PubMed ID: 16236092
    [Abstract] [Full Text] [Related]

  • 9. Oral almotriptan: practical uses in the acute treatment of migraine.
    Dowson AJ.
    Expert Rev Neurother; 2004 May; 4(3):339-48. PubMed ID: 15853532
    [Abstract] [Full Text] [Related]

  • 10. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
    Dowson AJ, Massiou H, Lainez JM, Cabarrocas X.
    Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
    [Abstract] [Full Text] [Related]

  • 11. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
    Freitag F, Smith T, Mathew N, Rupnow M, Greenberg S, Mao L, Finlayson G, Wright P, Biondi D, AEGIS Investigator Study Group.
    Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
    [Abstract] [Full Text] [Related]

  • 12. Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials.
    Dahlöf CG, Pascual J, Dodick DW, Dowson AJ.
    Cephalalgia; 2006 Apr; 26(4):400-8. PubMed ID: 16556240
    [Abstract] [Full Text] [Related]

  • 13. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC, Gendolla A, Gebert I, Beneke M.
    Headache; 2005 Apr; 45(7):874-82. PubMed ID: 15985104
    [Abstract] [Full Text] [Related]

  • 14. Almotriptan and zolmitriptan in the acute treatment of migraine.
    Goadsby PJ, Massiou H, Pascual J, Diener HC, Dahlöf CG, Mateos V, Dowson AJ, Raets I, Cunha L, Färkkilä M, Manzoni GC.
    Acta Neurol Scand; 2007 Jan; 115(1):34-40. PubMed ID: 17156263
    [Abstract] [Full Text] [Related]

  • 15. Almotriptan: a review of pharmacology, clinical efficacy, and tolerability.
    Von S.
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S74-9. PubMed ID: 11859907
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC.
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [Abstract] [Full Text] [Related]

  • 17. Review of clinical trials using early acute intervention with oral triptans for migraine management.
    Dowson AJ, Mathew NT, Pascual J.
    Int J Clin Pract; 2006 Jun; 60(6):698-706. PubMed ID: 16805756
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine.
    Allais G, Acuto G, Cabarrocas X, Esbri R, Benedetto C, Bussone G.
    Neurol Sci; 2006 May; 27 Suppl 2():S193-7. PubMed ID: 16688629
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Use of almotriptan in triptan-experienced and triptan-naïve patients.
    Pascual J, Diener HC.
    Curr Med Res Opin; 2007 Oct; 23(10):2433-40. PubMed ID: 17723158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.